ArticleCureus2026
Reticular Erythematous Mucinosis Mimicking a Vascular Dermatosis: A Clinicopathologic Diagnostic Challenge.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reticular erythematous mucinosis (REM) is a rare primary cutaneous mucinosis characterized by dermal mucin deposition and a chronic, indolent clinical course. Because of its nonspecific clinical presentation, REM may mimic a broad spectrum of inflammatory, connective tissue, and vascular dermatoses, frequently resulting in delayed diagnosis and inappropriate management. We report the case of a 57-year-old man with no significant past medical history who presented with a four-year history of a slowly progressive, occasionally pruritic eruption involving the upper back. The lesions gradually enlarged before stabilizing and failed to respond to multiple courses of topical corticosteroids. Clinical examination revealed grouped erythematous macules and papules coalescing into a reticulated erythematous plaque with a pseudo-vascular appearance. Dermoscopic examination performed with a polarized DermLite DL5 (3Gen Inc., San Juan Capistrano, CA, USA) demonstrated a diffuse pink background with fine irregular telangiectasias and multiple whitish structureless areas. Routine laboratory investigations, including antinuclear antibody testing, were unremarkable. Histopathological examination revealed a superficial and deep perivascular and periappendageal lymphohistiocytic infiltrate, while Alcian blue staining demonstrated dermal mucin deposition. Immunohistochemical analysis showed a predominantly T-cell infiltrate with scattered B lymphocytes, rare CD30-positive cells, and a few plasma cells, supporting a reactive inflammatory process. Integration of the clinical, dermoscopic, histopathological, and immunohistochemical findings established the diagnosis of REM. As the eruption was minimally symptomatic and clinically stable, the patient declined treatment, and no disease progression was observed during follow-up. This case expands the clinical spectrum of REM by illustrating an uncommon pseudo-vascular presentation in a male patient. It underscores the pivotal role of clinicodermoscopic-pathologic correlation in establishing the diagnosis of atypical presentations and avoiding unnecessary investigations, inappropriate treatments, and diagnostic delay.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.